One Mission: Zero Seizures.
Fédération Hospitalo-Universitaire (FHU) “Epilepsy and Disorders of Neuronal Excitability”
Prague, Czech Republic
Registrations are now open with reduced rates until March 30th
Knighthood for Epinext member Rosa Cossart
Rosa Cossart, team leader at the INMED, received an “consolidator” grant from the European Research Council (ERC) and was named Knight of the French National Order of Merit (Chevalier de l’Ordre de Mérite)
Co-Organiser of the conference “Linking cellular properties to neuronal network dynamics”
Every day, 65 million people in the world are hoping for a cure – for Epilepsy.
Epilepsy isn‘t exactly rare. 1% of the worldwide population is affected, that‘s 1 person in every 100 people.
Like Prince, the musician: “I used to have seizures when I was young. My mother and father didn't know what to do or how to handle it.”
Or actor Hugo Weaving (known as Agent Smith from The Matrix blockbuster trilogy): “I probably had one major seizure a year. Every now and then I’d fall down and wake up to someone saying, 'Are you OK?'”
Located in the Marseille area, Epinext is one of the largest multi-disciplinary structures in France which focuses on epilepsy diagnosis, research and treatment.
It brings together five established world leaders in clinical epileptology, fundamental epilepsy research and computational neuroscience…
There is no single disease called “Epilepsy”. Actually, doctors have identified numerous forms of epilepsy until today, several of them only in the past 10 years. Each form of epilepsy calls for different diagnostic validation, varies in severeness and responds very differently to drugs or surgery.
At the heart of the Epinext federation is the translation of results from basic research and computational neuroscience into clinical practice, i.e. developing new therapeutic strategies for epilepsy.
Epinext strives to share their research results, actual patient cases and data, success stories and dead ends with the international science community as well as the general public.